Skip to content
StockMarketAgent
Sector pending / Medical LaboratoriesUpdated 2026-05-10 22:07 UTC

FRA/7F0 stock hub

FRA/7F0 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

FRA/7F0is not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
385.1M
Frankfurt Stock Exchange
Market data

Price

Recent price action with selectable time range.

FRA/7F0FRA/7F0
Loading chart…
In the news

Latest news · FRA/7F0

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a
P25 n/aP50 n/aP75 n/a
Trailing P/En/a
P25 n/aP50 n/aP75 n/a
ROE-6.9
P25 n/aP50 n/aP75 n/a
ROIC-13
P25 n/aP50 n/aP75 n/a
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All FRA/7F0 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
167
Groups with data
11
Currency
USD
Showing 167 of 167 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

18
MetricValue
Country
United States
Country code
DE
Employees
1,315
Employees Change
129%
Employees Change Percent
10.9
Enterprise value
EUR -124.7M
Exchange
Frankfurt Stock Exchange
Financial currency
USD
First seen
2026-05-10
Industry
Medical Laboratories
Last refreshed
2026-05-10
Market cap
EUR 385.1M
Price
EUR 12.8
Price currency
EUR
Rev Per Employee
211,282.19x
Sic
8071
Symbol
fra/7F0
Website
https://www.fulgentgenetics.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

6
MetricValue
Earnings Yield
-16.62%
EV Earnings
1.95x
EV/FCF
1.27x
FCF yield
-25.49%
P/B ratio
0.43x
P/S ratio
1.39x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

19
MetricValue
EBIT Margin
-31.65%
EBITDA Margin
-24.1%
Gross margin
38.71%
Gross Profit
EUR 107.6M
Gross Profit Growth
9.31%
Gross Profit Growth Q
-24.19%
Gross Profit Growth3 Y
-4.67%
Gross Profit Growth5 Y
-27.37%
Net Income
EUR -64M
Pretax Margin
-26.31%
Profit Margin
-23.04%
Profit Per Employee
EUR -48,680
ROA
-5.37
Roa5y
7.85
ROCE
-9.51
ROE
-6.92
Roe5y
9.21
ROIC
-13.03
Roic5y
17.17

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

7
MetricValue
Cagr1y
-22.44%
Cagr3y
-20.68%
Cagr5y
-27.17%
Revenue Growth
9.54x
Revenue Growth Q
-3.17x
Revenue Growth3 Y
-4.25x
Revenue Growth5 Y
-16.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

19
MetricValue
Asset Turnover
EUR 0.27
Assets
EUR 1B
Cash
EUR 239.6M
Current Assets
EUR 406.2M
Current Liabilities
EUR 76.4M
Debt
EUR 8.8M
Debt Equity
EUR 0.01
Debt FCF
EUR -0.09
Equity
EUR 905.6M
Interest Coverage
-1,300
Liabilities
EUR 97.3M
Long Term Assets
EUR 596.7M
Long Term Liabilities
EUR 20.9M
Net Cash
EUR 515.5M
Net Cash By Market Cap
EUR 134
Net Cash Growth
-26.26%
Net Debt Equity
EUR -0.57
Tangible Book Value
EUR 730.3M
Tangible Book Value Per Share
EUR 25.31

Liquidity

Current-asset coverage and working-capital efficiency metrics.

5
MetricValue
Current ratio
5.31
Net Working Capital
EUR 100M
Quick ratio
3.91
Working Capital
EUR 337.3M
Working Capital Turnover
EUR 0.75

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

1
MetricValue
Buyback Yield
-0.95%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

34
MetricValue
1Y total return
-22.42%
200-day SMA
18.86
3Y total return
-50.1%
50-day SMA
13.44
50-day SMA vs 200-day SMA
50under200
5Y total return
-79.5%
All Time High
150
All Time High Change
-91.47%
All Time High Date
2021-02-10
All Time Low
5.95
All Time Low Change
115.13%
All Time Low Date
2020-03-17
ATR
0.34
Ch YTD
-42.86
High
12.8
High52
26.6
High52 Date
2025-11-26
High52ch
-51.88%
Low
12.8
Low52
11.8
Low52 Date
2026-03-04
Low52ch
8.48%
Ma50ch
-4.79%
Price vs 200-day SMA
-32.12%
RSI
43.75
RSI Monthly
38.52
RSI Weekly
34.85
Sharpe ratio
-0.32x
Sortino ratio
-0.32
Total Return
-0.95%
Tr YTD
-42.86
Tr1m
-9.22%
Tr1w
6.67%
Tr3m
-35.68%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

2
MetricValue
Operating Income
EUR -87.9M
Operating margin
-31.65

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

7
MetricValue
Float
17,733,277%
Net Borrowing
-702,112.5
Shares Insiders
37.56%
Shares Institutions
64.36%
Shares Qo Q
-0.32%
Shares Yo Y
0.95%
Short Ratio
4.24

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

49
MetricValue
Adjusted FCF
EUR -131.9M
Average Volume
0x
Bv Per Share
31.56
CAPEX
EUR -20M
Ch1m
-9.22
Ch1w
6.67
Ch1y
-22.42
Ch3m
-35.68
Ch3y
-50.1
Ch5y
-79.5
Ch6m
-37.86
Change
1.59%
Change From Open
0
Close
12.6
Days Gap
1.59
Depreciation Amortization
20,524,072.2
Earnings Date
2026-05-01
EBIT
EUR -87.9M
EBITDA
EUR -67M
EPS
EUR -2.08
F Score
2
FCF
EUR -98.2M
FCF EV Yield
78.7x
Financing CF
-42,020,685
Fiscal Year End
December
Founded
2,011
Goodwill
45,561,846.2
Income Tax
EUR -8M
Investing CF
82,030,101
Is Primary Listing
0
Last Earnings Date
2026-05-01
Last Report Date
2026-03-31
Ma150
19.16
Ma150ch
-33.19%
Ma20
13.14
Ma20ch
-2.59%
Net CF
-38,058,859
Open
12.8
Ppne
105,388,957.2
Price Date
2026-05-08
Ptbv Ratio
0.53
Relative Volume
2,000x
Revenue
277,836,086x
SBC By Revenue
12.15x
Share Based Comp
33,757,051
Tax By Revenue
-2.89x
Tr6m
-37.86%
Volume
0
Z Score
4.61
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does FRA/7F0 pay a dividend?

Capital-return profile for this ticker.

Performance

FRA/7F0 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-22.4%
S&P 500 1Y: n/a
3Y total return
-50.1%
S&P 500 3Y: n/a
5Y total return
-79.5%
S&P 500 5Y: n/a
10Y total return
n/a
S&P 500 10Y: n/a
Ownership

Who owns FRA/7F0?

Insider, institutional, and short-interest positioning.

Institutional ownership
+64.4%
Share of float held by funds and institutions
Insider ownership
+37.6%
Stake held by company insiders. Higher generally signals alignment.
Short interest
n/a
4.2 days to cover
Y/Y dilution
+0.9%
Negative means the company is buying back shares.
Technical

FRA/7F0 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
43.7
Neutral momentum band
Price vs 200-day MA
-32.1%
50/200-day relationship not available
Beta (5Y)
n/a
Sensitivity to the broader market
Sharpe ratio
-0.32
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About FRA/7F0

Hub-level FAQ points readers to the deeper analysis pages.

What is the current fra/7F0 stock rating?

fra/7F0 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full fra/7F0 analysis?

The full report lives at /stocks/fra/7F0/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for fra/7F0?

The latest report frames fra/7F0 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the fra/7F0 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.